Head to Head Survey: Pro-Dex (NASDAQ:PDEX) and Retractable Technologies (NYSE:RVP)

Pro-Dex (NASDAQ:PDEX) and Retractable Technologies (NYSE:RVP) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, risk, analyst recommendations, earnings, dividends and institutional ownership.

Profitability

This table compares Pro-Dex and Retractable Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Pro-Dex	5.59%	8.97%	5.40%
Retractable Technologies	-16.08%	-6.86%	-3.78%

Analyst Recommendations

This is a summary of current recommendations for Pro-Dex and Retractable Technologies, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pro-Dex	0	0	0	0	N/A
Retractable Technologies	0	0	0	0	N/A

Earnings & Valuation

This table compares Pro-Dex and Retractable Technologies’ gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pro-Dex	$46.09 million	1.42	$7.07 million	$0.75	24.80
Retractable Technologies	$43.60 million	0.73	-$7.01 million	($0.24)	-4.46

Pro-Dex has higher revenue and earnings than Retractable Technologies. Retractable Technologies is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

Institutional & Insider Ownership

15.3% of Pro-Dex shares are held by institutional investors. Comparatively, 7.6% of Retractable Technologies shares are held by institutional investors. 42.6% of Pro-Dex shares are held by insiders. Comparatively, 54.6% of Retractable Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Volatility & Risk

Pro-Dex has a beta of 0.6, suggesting that its share price is 40% less volatile than the S&P 500. Comparatively, Retractable Technologies has a beta of 2.11, suggesting that its share price is 111% more volatile than the S&P 500.

Summary

Pro-Dex beats Retractable Technologies on 9 of the 11 factors compared between the two stocks.

About Pro-Dex

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

About Retractable Technologies

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. The company was incorporated in 1994 and is headquartered in Little Elm, Texas.